Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-314P encodes a **pseudogene copy** of U6 small nuclear RNA (snRNA), specifically the 314th annotated U6 snRNA-derived pseudogene in the human genome[4][5]. U6 snRNA is an essential component of the spliceosome machinery, critical for the splicing of precursor mRNA in eukaryotes[3][1]. However, RNU6-314P itself is a non-functional genetic element: it consists of DNA sequence homologous to genuine U6 snRNA but does not produce functionally active snRNA[5]. U6 snRNA pseudogenes, such as RNU6-314P, likely represent fossil sequences produced by retrotransposition events and show substantial sequence homology (typically >75%) to functional U6 snRNA genes[5][6]. These pseudogenes *do not participate in spliceosomal function*, are not known to be involved in disease, are not targeted by drugs, and are not applicable to patient biomarker selection[4][6]. They may serve as genomic markers for studying the dynamics and frequency of retrotransposition in mammalian genomes[6]. **Notable context:** - There are hundreds of U6 snRNA pseudogenes in the human genome, but their only established role is as *genomic relics* or potential evolutionary markers, not as functional RNA molecules[6]. - No evidence supports their utility as therapeutic targets or direct clinical relevance[4][6]. If you require information on the **functional parent molecule**, refer to **U6 small nuclear RNA (snRNA)**, which plays a central role in pre-mRNA splicing[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 314, pseudogene (RNU6-314P).